These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32591439)

  • 41. Estimated Pulse Wave Velocity and Cognitive Outcomes: A Post hoc Analysis of SPRINT-MIND.
    Hao P; Feng S; Suo M; Wang S; Zheng K; Wu X
    Am J Hypertens; 2024 Jun; 37(7):485-492. PubMed ID: 38488616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Zelniker TA; Raz I; Mosenzon O; Dwyer JP; Heerspink HHJL; Cahn A; Goodrich EL; Im K; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Gause-Nilsson I; Langkilde AM; Sabatine MS; Wiviott SD
    JAMA Cardiol; 2021 Jul; 6(7):801-810. PubMed ID: 33851953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intensive Blood Pressure Treatment and Subclinical Brain Infarcts: A Secondary Analysis of SPRINT (Systolic Pressure Intervention Trial).
    Kern KC; Nasrallah IM; Bryan RN; Williamson J; Reboussin DM; Pajewski NM; Wright CB
    Ann Neurol; 2024 May; 95(5):866-875. PubMed ID: 38362733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Processing speed is affected by early impairment in kidney function in the general elder population.
    Månsson T; Elmståhl S
    BMC Nephrol; 2021 Sep; 22(1):314. PubMed ID: 34548062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of Midlife to Late-Life Blood Pressure Patterns With Incident Dementia.
    Walker KA; Sharrett AR; Wu A; Schneider ALC; Albert M; Lutsey PL; Bandeen-Roche K; Coresh J; Gross AL; Windham BG; Knopman DS; Power MC; Rawlings AM; Mosley TH; Gottesman RF
    JAMA; 2019 Aug; 322(6):535-545. PubMed ID: 31408138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.
    Ryan J; Storey E; Murray AM; Woods RL; Wolfe R; Reid CM; Nelson MR; Chong TTJ; Williamson JD; Ward SA; Lockery JE; Orchard SG; Trevaks R; Kirpach B; Newman AB; Ernst ME; McNeil JJ; Shah RC;
    Neurology; 2020 Jul; 95(3):e320-e331. PubMed ID: 32213642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients.
    Aggarwal R; Petrie B; Bala W; Chiu N
    Hypertension; 2019 Jun; 73(6):1275-1282. PubMed ID: 31067189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute Declines in Estimated GFR in Blood Pressure Target Trials and Risk of Adverse Outcomes.
    Ku E; McCulloch CE; Copeland TP; Inker LA; Tighiouart H; Sarnak MJ
    Am J Kidney Dis; 2023 Oct; 82(4):454-463. PubMed ID: 37269972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diastolic Blood Pressure and Intensive Blood Pressure Control on Cognitive Outcomes: Insights From the SPRINT MIND Trial.
    Jiang C; Li S; Wang Y; Lai Y; Bai Y; Zhao M; He L; Kong Y; Guo X; Li S; Liu N; Jiang C; Tang R; Sang C; Long D; Du X; Dong J; Anderson CS; Ma C
    Hypertension; 2023 Mar; 80(3):580-589. PubMed ID: 36688305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events.
    Rathi N; Whelton PK; Chertow GM; Cushman WC; Cheung AK; Wei G; Boucher R; Kimmel PL; Bress AP; Kramer HJ; Al-Marji C; Greene T; Beddhu S
    Am J Hypertens; 2019 Nov; 32(12):1170-1177. PubMed ID: 31257407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypertension and Mild Cognitive Impairment: State-of-the-Art Review.
    Shajahan S; Peters R; Carcel C; Woodward M; Harris K; Anderson CS
    Am J Hypertens; 2024 May; 37(6):385-393. PubMed ID: 38214550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.
    Weiner DE; Park M; Tighiouart H; Joseph AA; Carpenter MA; Goyal N; House AA; Hsu CY; Ix JH; Jacques PF; Kew CE; Kim SJ; Kusek JW; Pesavento TE; Pfeffer MA; Smith SR; Weir MR; Levey AS; Bostom AG
    Am J Kidney Dis; 2019 Jan; 73(1):51-61. PubMed ID: 30037726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of mean blood pressure and blood pressure variability after diagnosis of mild cognitive impairment and risk of dementia.
    de Havenon A; Muddasani V; Anadani M; Prabhakaran S
    J Clin Hypertens (Greenwich); 2021 Dec; 23(12):2124-2128. PubMed ID: 34862714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood Pressure and Statin Effects on Cognition: a Review.
    Yang M; Williamson J
    Curr Hypertens Rep; 2019 Jul; 21(9):70. PubMed ID: 31350600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy.
    Vaduganathan M; Pareek M; Kristensen AMD; Biering-Sørensen T; Byrne C; Almarzooq Z; Olesen TB; Olsen MH; Bhatt DL
    Eur J Heart Fail; 2021 Mar; 23(3):384-392. PubMed ID: 33448580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Body-mass index and the risk of albuminuria in hypertensive patients with a poor estimated glomerular filtration rate and the potential role of diabetes mellitus.
    Raikou VD; Gavriil S
    Diabetes Metab Syndr; 2019; 13(2):1041-1046. PubMed ID: 31336441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of visit-to-visit blood pressure variability on mild cognitive impairment and probable dementia in hypertensive patients receiving standard and intensive blood pressure treatment.
    Guo H; Tan Y; Yao Z; Zhang Z; Yan J; Meng X
    Front Cardiovasc Med; 2023; 10():1166554. PubMed ID: 37139135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study.
    Matsushita K; Kwak L; Sang Y; Ballew SH; Skali H; Shah AM; Coresh J; Solomon S
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-Term Blood Pressure Variability and Kidney Function in Participants of the ASPREE Trial.
    Ernst ME; Fravel MA; Webb KL; Wetmore JB; Wolfe R; Chowdhury E; Reid CM; Woods RL; Beilin L; Margolis KL; Murray AM; Polkinghorne KR
    Am J Hypertens; 2022 Feb; 35(2):173-181. PubMed ID: 34519331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.